Nova Biomedical is One of the World’s Fastest Growing In Vitro Diagnostics Companies:

Nova Biomedical is the largest privately held in vitro diagnostics (IVD) company in the United States and the third largest in the world, employing over 1,500 people. Our eight percent compound annual growth rate over nearly a decade is nearly triple the average IVD market growth, making Nova one of the fastest growing IVD companies in the world.

Nova’s size and rapid growth are the result of customers throughout the world responding to the exceptional quality and value of Nova’s technology, products, and customer service. Our strong corporate commitment to these three areas has made Nova a world leader in critical care testing, point-of-care (POC) testing, and cell culture analysis for biochemistry.

Worldwide Market Areas Include:

Hospital Blood Gas and Critical Care Analyzers
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.

Clinic / Doctor's Office, Blood Bank, Pre-Hospital / Ambulance, Veterinary and Sports Medicine
Measurements in these markets include HbA1c, Lipids, UACR, PT/INR, CRP, Glucose, Ketone, Lactate and Hb / Hct

Chemistry and Cell Culture Analyzers for Biotechnology
Nova manufactures a series of BioProfile^® automated cell culture analyzers for rapid analysis of key nutrients, metabolites, pH, gases, and cell density/cell viability.

Self-Testing Diabetes Meters
Nova develops and manufactures blood glucose meters and test strips for self-testing by patients with diabetes. The glucose meters are distributed under the Nova Max^® label in the U.S. and Canada, the Menarini label in Europe and the Walgreen's label in the U.S.

Product Development and Manufacturing for Corporate Partners
In addition to Nova products, we develop and manufacture medical devices and diagnostic products for many of the world’s leading healthcare corporations.

Pioneering Technological Innovations
Nova Biomedical has a 40-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use.

Measurement Technologies Used by Nova Analyzers

Potentiometric (whole blood or plasma), Amperometric (whole blood/plasma or cell culture media), Conductivity (whole blood), Immunochemistry (whole blood or plasma), Spectrophotometric (plasma and cell culture media), Photometric (lysed whole blood), Ellipsometry (saliva/urine), and Imaging (cell culture).

Directed by Medical Science

Nova’s advanced technology is directed by our involvement with the clinical and medical communities. Through our Medical and Scientific Affairs department, we work with clinicians throughout the world to find areas of clinical need that can be improved through the application of our measurement technologies. We also encourage studies of our products in patient populations that stress the limits of analytical performance. Hundreds of scientific papers have been published in peer-reviewed journals validating the excellent performance of our products in medical areas such as sepsis and septic shock, foetal distress, acute kidney injury, severe burn, neonatology, oncology, and cardiac surgery.

A Global Company

Nova has sales and service operations in 100 countries, through subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Australia, Benelux, Brazil, Canada, France, Germany, Italy, Japan, New Zealand, Spain, Switzerland, the United Kingdom, and the United States. Nova’s subsidiaries and distributors provide product information, demonstrations, local inventory, and complete technical support. Whether you are located in North America, Europe, Russia, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your critical care and POC testing needs.

Nova’s global manufacturing operations take place in facilities located in Waltham and Billerica, Massachusetts, U.S., and Taipei, Taiwan. These facilities occupy a total of 525,000 square meters (49,000 square feet) of manufacturing space.

International Distributors

Nova has sales and service operations in 100 countries, with distributors in 92 of them. Distributors provide information, demonstrations, local inventory, and technical support.

Corporate Headquarters

United States - Waltham, MA
Nova Biomedical Corporation
200 Prospect Street
Waltham, MA, USA 02454-9141 USA
Telephone: +1-781-894-0800
FAX: +1-781-894-5915
info@novabiomedical.com

Subsidiaries

Australia - Chatswood, NSW
Benelux - Den Bosch, Netherlands
Brazil - Belo Horizonte
Canada - Mississauga, Ontario
France - Les Ulis, Courtaboeuf
Germany - Mörfelden-Walldorf
Italy - Lainate (Mi)
Japan - Minato-ku, Tokyo
New Zealand - Rosedale
Spain - Barcelona
Switzerland - Zurich
United Kingdom - Runcorn, Cheshire

International Salaes and Support Offices

Africa - Hamburg, Germany
Asia Pacific - Hong Kong, China Central and South America- Miami, FL, EU
Eastern Europe - London, UK
Middle East - Dubai, UAE.
Russia - Hamburg, Germany
Eastern Europe - Siena, Italy

Factories

United States - Waltham, MA and Billerica, MA.

Taiwan-Taipei

International Distributors

92 distributors around the world